TriangleRadiation therapy (NCT07364071)
Radiation therapy trial for Prostate Adenocarcinoma (NCT07364071). This is a short film with English narration. The transcript is on this page, and the written brief is separate.
What the film says
Read the transcript
This trial is for adult men with high-risk localized prostate adenocarcinoma without distant spread or clear regional nodes on conventional imaging. Patients must plan definitive radiation and hormone treatment.
The idea: patients are randomized to radiation with six or eighteen months of androgen deprivation. The shorter arm may also add an androgen-receptor pathway inhibitor when indicated. Researchers test whether shorter treatment preserves cancer control. Follow-up tracks additional hormone treatment, castration resistance, and survival for five years.
This phase 2 study plans 150 patients. Tyler Seibert leads at UC San Diego's sole recruiting site.
Public record; not medical advice.
Already in a trial?
It turns into a project to manage: visits, scans, labs, side effects and paperwork. Triangle keeps it organized in one place for you or for whoever's helping.
Organize my trial7-day free trial, then $9 a month. Cancel anytime.